Growth Metrics

Resmed (RMD) Asset Writedowns and Impairment (2016 - 2020)

Resmed's Asset Writedowns and Impairment history spans 10 years, with the latest figure at $9.1 million for Q1 2020.

  • For Q1 2020, Asset Writedowns and Impairment rose 55.77% year-over-year to $9.1 million; the TTM value through Mar 2020 reached $20.7 million, up 23.55%, while the annual FY2019 figure was $15.0 million, 29.45% up from the prior year.
  • Asset Writedowns and Impairment reached $9.1 million in Q1 2020 per RMD's latest filing, up from $2.8 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $9.1 million in Q1 2020 to a low of -$2.1 million in Q2 2016.
  • Average Asset Writedowns and Impairment over 5 years is $2.9 million, with a median of $1.7 million recorded in 2018.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 81.5% in 2017, then skyrocketed 483.25% in 2018.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$2.1 million in 2016, then soared by 162.57% to $1.3 million in 2017, then decreased by 3.41% to $1.2 million in 2018, then soared by 126.68% to $2.8 million in 2019, then soared by 221.67% to $9.1 million in 2020.
  • Per Business Quant, the three most recent readings for RMD's Asset Writedowns and Impairment are $9.1 million (Q1 2020), $2.8 million (Q4 2019), and $2.6 million (Q3 2019).